A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
NANOVIRICIDES, INC.
NNVC
$766K
Mkt Cap
$1.02
-1.92%
ITEM 1: BUSINESS Organization and Nature of Business NanoViricides, Inc. (the “Company”, “NanoViricides”, “we,” or “us”) was incorporated in Nevada on April 1, 2005, and redomiciled to Delaware effective May 30, 2023. Our corporate offices are located at 1 Controls Drive, Shelton, Connecticut 06484 and our telephone number is (203) 937-6137. Our Website is located at http://www.Nanoviricides.com. We do not incorporate by reference into this Annual Report the information on or accessible through our website, and you should not consider it part of this Annual Report. On September 25, 2013, the Company’s common stock began trading on the New York Stock Exchange American under the symbol, “NNVC”. We are a clinical stage company with our first drug ready to enter Phase II human clinical efficacy trial, having successfully completed Phase Ia/Ib human clinical safety and tolerability trial.
| Metric | TTM | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Net Income | -8.3M | -9.5M | -8.3M | -8.6M |
| EPS | $-0.49 | $-12.60 | $-14.00 | $-14.80 |
| Free Cash Flow | -7.4M | -8.5M | -6.5M | -5.8M |
| ROIC | -860.6% | 0.0% | 0.0% | 0.0% |
| Gross Margin | - | 0.0% | 0.0% | 0.0% |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividends/Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -8.4M | -9.6M | -8.5M | -8.9M |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE | -75.1% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | 22M | 1M | 1M | 1M |
| Metric | ||||
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 0 | 0 | 0 | 0 |
| Gross Margin | 0.0% | 0.0% | 0.0% | N/A |
| R&D | 6.4M | 5.4M | 5.5M | 4.6M |
| SG&A | 2.6M | 3.1M | 4.0M | 3.8M |
| EBIT | -8.9M | -8.5M | -9.6M | -8.4M |
| Op. Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -8.6M | -8.3M | -9.5M | -8.3M |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Recurring | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||
| ROIC | 0.0% | 0.0% | 0.0% | N/M |
| ROE | 0.0% | 0.0% | 0.0% | -75.1% |
| ROA | 0.0% | 0.0% | 0.0% | -67.8% |
| Cash Flow | ||||
| Op. Cash Flow | -5.7M | -6.3M | -8.5M | -7.3M |
| Free Cash Flow | -5.8M | -6.5M | -8.5M | -7.4M |
| Owner Earnings | -12M | -14M | -17M | -7.9M |
| CapEx | 152K | 157K | 57K | 95K |
| Maint. CapEx | 6.7M | 7.5M | 8.2M | 610K |
| Growth CapEx | 0 | 0 | 0 | 0 |
| D&A | 6.7M | 7.5M | 8.2M | 610K |
| CapEx/OCF | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||
| Dividends Paid | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 44K | 0 | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||
| Net Debt | N/A | N/A | N/A | -10M |
| Cash & Equiv. | 8.1M | 4.8M | 1.6M | 10M |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | -9534.6 | -171.0 | -64373.5 | -64373.5 |
| Equity | 0 | 0 | 0 | 11M |
| Total Assets | 0 | 0 | 0 | 12M |
| Total Liabilities | 2.0M | 1.4M | N/A | 48K |
| Intangibles | 334K | 325K | 317K | 626K |
| Retained Earnings | -131M | -139M | -149M | -153M |
| Working Capital | 7.9M | 3.6M | 364K | 4.1M |
| Current Assets | 8.4M | 5.0M | 1.7M | 5.3M |
| Current Liabilities | 534K | 1.4M | 1.3M | 1.2M |
| Per Share Data | ||||
| EPS | -14.80 | -14.00 | -12.60 | -0.49 |
| Owner EPS | -21.40 | -23.24 | -22.18 | -0.37 |
| Book Value | 0.00 | 0.00 | 0.00 | 0.51 |
| Cash Flow/Share | -9.77 | -10.66 | -11.28 | -0.36 |
| Dividends/Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Out. | 0.6M | 0.6M | 0.8M | 21.6M |
| Valuation | ||||
| P/E Ratio | N/A | N/A | N/A | -2.1 |
| P/FCF | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | 2.0 |
| Price/Sales | N/A | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A | -33.7% |
| Market Cap | 0 | 0 | 0 | 22M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 1.02 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 1.02 |
NANOVIRICIDES, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
NANOVIRICIDES, INC. (NNVC) has a market capitalization of $22M. It is classified as a small-cap stock.
NANOVIRICIDES, INC. (NNVC) does not currently pay a regular dividend.
NANOVIRICIDES, INC. (NNVC) generated $-9 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
NANOVIRICIDES, INC. (NNVC) has a debt-to-equity ratio of 0.00. This indicates a conservatively financed balance sheet.
NANOVIRICIDES, INC. (NNVC) reported earnings per share (EPS) of $-12.60 in its most recent fiscal year.
The Ledger Terminal provides 3 years of financial data for NANOVIRICIDES, INC. (NNVC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.